Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Nephrology 2, 606 (1 November 2006) | doi:10.1038/ncpneph0279
Serum CD30 and neopterin predict CAN: impact of immunosuppressant type
Abstract
Weimer R et al. (2006) Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens. Am J Transplant 6: 1865–1874 Immunosuppressive treatment tailored to individual renal transplant recipients might improve long-term graft and patient survival.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
